Phospho-CAV2 (Tyr27) Antibody

Shipped with Ice Packs
In Stock

Product Specs

Form
Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Lead Time
Typically, we are able to ship the products within 1-3 business days of receiving your order. The delivery time may vary depending on the shipping method and destination. Please consult your local distributor for specific delivery times.
Synonyms
CAV antibody; CAV2 antibody; CAV2_HUMAN antibody; Caveolae protein 20 kD antibody; Caveolin 2 antibody; Caveolin 2 isoform a and b antibody; Caveolin-2 antibody; MGC12294 antibody; OTTHUMP00000025032 antibody; OTTHUMP00000195982 antibody
Target Names
Uniprot No.

Target Background

Function
Caveolin-2 may function as a scaffolding protein within caveolar membranes. It directly interacts with G-protein alpha subunits and can regulate their activity. Caveolin-2 acts as an accessory protein in conjunction with caveolin-1 in targeting lipid rafts and promoting caveolae formation. Phosphorylation of Caveolin-2 at serine 36 is involved in modulating mitosis in endothelial cells. Caveolin-2 acts as a positive regulator of cellular mitogenesis in the MAPK signaling pathway. It is essential for the insulin-stimulated nuclear translocation and activation of MAPK1 and STAT3, subsequently regulating cell cycle progression.
Gene References Into Functions
  1. The Cav-2beta isoform, produced by alternative translation initiation, desensitizes the insulin receptor (IR) via dephosphorylation by PTP1B, leading to endocytosis and lysosomal degradation of IR, ultimately causing insulin resistance. PMID: 29604334
  2. Research confirmed the presence of transcript III of cav-2 for the first time, although no associated protein was detected. Additionally, a decreasing trend of cav-2 (transcripts I and II) was observed in tumoral tissues, particularly in stages I and II, suggesting a potential association with the incidence and promotion of breast cancer, especially in the early stages. PMID: 28857238
  3. High CAV2 expression has been linked to lung cancer. PMID: 26930711
  4. A-type lamin-dependent Caveolin-2 homo-oligomerization in the inner nuclear membrane microdomain is a prerequisite for pY19-Caveolin-2-mediated insulin-response epigenetic activation at the nuclear periphery. PMID: 27552914
  5. Caveolin-2 expression is crucial for the regulation of E2-dependent cellular proliferation in MCF-7 cells. PMID: 26480297
  6. A variant in CAV2 has been associated with an increased age of onset of P. aeruginosa airway infection in a cystic fibrosis cohort. PMID: 26047157
  7. Findings present initial characterization of key proteins Cav2 and CFL1 as cellular factors that colocalize with M in viral inclusions and filaments. Additionally, ZNF502 protein appears to interact with RSV M in the nucleus. PMID: 25556234
  8. Research results did not align with previous positive findings, suggesting that CAV1-CAV2 variants studied in this particular study are not significant risk factors for Normal Tension Glaucoma. PMID: 23743525
  9. This study does not support an association between CAV2 variation and kidney transplant survival. PMID: 23667606
  10. The combined expression of genes for PPARgamma, STMN1, and CAV2 was significantly predictive of early recurrence of non-muscle-invasive bladder cancer. PMID: 21489836
  11. In contrast to wild-type-Cav-2, retroviral re-expression of Y19/27F-Cav-2 in Cav-2 knockout endothelial cells did not affect the anti-proliferative effect of TGF-beta compared to an empty vector. PMID: 22819829
  12. Stromal caveolin-2 expression was more frequent in anaplastic carcinoma and the diffuse sclerosing variant of papillary carcinoma compared to conventional papillary thyroid carcinoma. PMID: 22236542
  13. CAV1 mRNA and protein levels are reduced by both NFBD1 knockdown and knockout, independent of IR and p53. PMID: 21551225
  14. Cav-2 acts as a modulator of cancer progression. PMID: 21373752
  15. Preliminary evidence suggests that CAV2 rs2270188 interacts with dietary fat to influence the risk of type 2 diabetes. PMID: 21178094
  16. Single Nucleotide Polymorphisms in CAV2 have been associated with primary open-angle glaucoma. PMID: 20835238
  17. In Caco-2 cells, a polarized cell line derived from human colon cancer that does not express caveolin 1 (Cav-1), there was no detectable expression of caveolin 2 (Cav-2). PMID: 12414992
  18. Caveolin-2 may play a role in lamellar granule assembly, trafficking, and/or function. PMID: 12648214
  19. PPARgamma ligands increased caveolin-2 levels 2-5-fold in a concentration-dependent manner within 24 hours. Nonthiazolidinedione PPARgamma ligands elevated caveolin-2 protein 3-4-fold. PMID: 12813462
  20. New evidence demonstrates that Cav-2 undergoes phosphorylation at both tyrosines 19 and 27. Notably, tyrosine phosphorylation of Cav-2 does not affect its targeting to lipid rafts but clearly disrupts hetero-oligomerization of Cav-2 with Cav-1. PMID: 15504032
  21. Heterologously and endogenously expressed D1 dopamine receptors in renal cells are associated with and regulated by caveolin-2. PMID: 15569306
  22. Overexpression of caveolin-2 is associated with inflammatory breast cancer. PMID: 16244790
  23. CAV2 was identified and immunolocalized in the caveola-vesicle complexes (CVC) present in erythrocytes infected with P. vivax. PMID: 16521037
  24. Caveolin-2 was expressed in the sinusoidal endothelial cells and the smooth muscle cells of the unpaired arteries of hepatocellular carcinoma specimens. PMID: 17898556
  25. CAV2 is preferentially expressed in basal-like cancers and is associated with poor prognosis. PMID: 17912630
  26. Data suggests a potential involvement of serine 36-phosphorylated caveolin-2 in modulating mitosis. PMID: 18081315

Show More

Hide All

Database Links

HGNC: 1528

OMIM: 601048

KEGG: hsa:858

STRING: 9606.ENSP00000222693

UniGene: Hs.212332

Protein Families
Caveolin family
Subcellular Location
Nucleus. Cytoplasm. Golgi apparatus membrane; Peripheral membrane protein. Cell membrane; Peripheral membrane protein. Membrane, caveola; Peripheral membrane protein.
Tissue Specificity
Expressed in endothelial cells, smooth muscle cells, skeletal myoblasts and fibroblasts.

Q&A

What is the Phospho-CAV2 (Tyr27) Antibody and what does it specifically detect?

The Phospho-CAV2 (Tyr27) Antibody is a rabbit polyclonal antibody that specifically detects endogenous levels of Caveolin-2 (CAV2) only when phosphorylated at tyrosine 27. This antibody does not cross-react with non-phosphorylated CAV2 at this position, making it valuable for studying the phosphorylation status of this protein in experimental systems . The specificity for the phosphorylated form is achieved through careful purification processes that remove non-phospho specific antibodies through chromatography using non-phosphopeptides .

What are the recommended applications for this antibody?

This antibody has been validated for the following applications:

  • Western Blotting (WB): Primary application with dilution ranges of 1:500-1:1000

  • ELISA: Secondary application with recommended dilutions of 1:5000 to 1:20000

The antibody has not been broadly validated for immunohistochemistry, immunofluorescence, immunoprecipitation, or flow cytometry applications based on the available data.

What is the recommended storage and handling protocol for optimal antibody performance?

For optimal performance and stability:

  • Ship at 4°C

  • Upon delivery, aliquot to minimize freeze-thaw cycles

  • Store aliquots at -20°C for up to 1 year

  • Avoid repeated freeze-thaw cycles as they may denature the antibody and reduce its efficacy

How should I optimize Western blotting protocols when using this antibody?

For optimal results in Western blotting experiments:

  • Sample preparation:

    • Use fresh tissues or cells when possible

    • Include phosphatase inhibitors in lysis buffers to prevent dephosphorylation

    • Maintain cold temperatures during sample preparation

  • Blotting conditions:

    • Start with recommended dilution of 1:500

    • Incubate membranes overnight at 4°C for best signal-to-noise ratio

    • Use 5% BSA in TBST for blocking and antibody dilution (not milk, which contains phosphatases)

    • Include positive controls (lysates known to contain phosphorylated CAV2)

    • Include negative controls (treated with phosphatases)

  • Detection:

    • Use high-sensitivity ECL reagents for optimal detection of potentially low-abundance phosphorylated proteins

    • Expected molecular weight: 18-26 kDa (variations exist between sources)

How can I validate antibody specificity in my experimental system?

To confirm antibody specificity:

  • Peptide competition assay:

    • Pre-incubate antibody with excess phospho-peptide containing the Tyr27 site

    • This should abolish specific signal in Western blot

  • Phosphatase treatment:

    • Treat half of your samples with alkaline phosphatase

    • The signal should disappear in treated samples

  • Knockout/knockdown controls:

    • Use CAV2 knockout or knockdown samples as negative controls

    • No band should be detected at the expected molecular weight

  • Stimulus-dependent phosphorylation:

    • Use treatments known to induce or inhibit CAV2 phosphorylation

    • Observe corresponding changes in signal intensity

What signaling pathways regulate CAV2 Tyr27 phosphorylation?

CAV2 Tyr27 phosphorylation appears to be regulated by several kinase pathways:

  • Src family kinases (SFKs):

    • SFKs are primary mediators of tyrosine phosphorylation in caveolins

    • Studies suggest that Src can phosphorylate CAV2 at Tyr27 directly or indirectly

  • Receptor tyrosine kinase (RTK) signaling:

    • Growth factor stimulation (e.g., EGF, PDGF) may lead to CAV2 phosphorylation

    • The α1-Adrenergic receptor–PKC–Pyk2–Src signaling pathway has been shown to increase phosphorylation of various targets and may affect CAV2

  • Calcium-dependent signaling:

    • The role of calcium in CAV2 phosphorylation remains to be fully characterized, but calcium-mediated signaling pathways involving Pyk2 activation may contribute to tyrosine phosphorylation events

How does Tyr27 phosphorylation affect CAV2 function and localization?

Phosphorylation at Tyr27 appears to play crucial roles in several aspects of CAV2 biology:

  • Membrane trafficking:

    • Phosphorylation may regulate the movement of CAV2 between cellular compartments

    • May influence the formation or stability of caveolae structures

  • Protein-protein interactions:

    • Phosphorylation at Tyr27 likely creates binding sites for proteins containing SH2 or PTB domains

    • May influence CAV2's ability to interact with signaling molecules or other caveolae components

  • Relationship to cellular functions:

    • May influence endocytosis pathways

    • Could affect signal transduction through caveolae-associated receptors

How can I investigate the relationship between CAV2 phosphorylation and ion channel regulation?

Recent research suggests connections between caveolins and ion channel regulation. To investigate this relationship:

  • Co-immunoprecipitation studies:

    • Use Phospho-CAV2 (Tyr27) antibody to immunoprecipitate phosphorylated CAV2

    • Probe for potential interactions with calcium channels like Cav2.1 or Cav2.2

  • Functional studies:

    • Compare channel activity in conditions that promote or inhibit CAV2 phosphorylation

    • Patch-clamp experiments before and after treatments that affect phosphorylation status

  • Advanced microscopy:

    • Use fluorescently tagged constructs alongside phospho-specific antibodies

    • Investigate co-localization of phosphorylated CAV2 with ion channels

  • Mutation studies:

    • Utilize Y27F (non-phosphorylatable) or Y27E (phosphomimetic) mutants of CAV2

    • Examine effects on channel localization, activity, and membrane dynamics

An interesting parallel is that phosphorylation has been shown to significantly influence voltage-gated calcium channel properties. For example, dephosphorylation of Cav3.2 T-type calcium channels shifts activation and inactivation curves toward more negative potentials by approximately 16-19 mV , suggesting that phosphorylation state dramatically affects channel function.

Why might I observe multiple bands when using the Phospho-CAV2 (Tyr27) antibody?

Multiple bands could appear for several reasons:

  • Isoforms and post-translational modifications:

    • CAV2 has multiple isoforms (α and β)

    • Additional post-translational modifications may alter mobility

  • Degradation products:

    • Ensure complete protease inhibition during sample preparation

    • Fresh preparation of samples can minimize degradation

  • Cross-reactivity:

    • While the antibody is specific for phospho-Tyr27, structural similarities in phosphorylated tyrosine motifs in other proteins may cause cross-reactivity

    • The sequence around the phosphorylation site (L-E-Y(p)-A-D) should be considered when evaluating potential cross-reactivity

What control experiments are essential when studying Tyr27 phosphorylation of CAV2?

Critical controls include:

  • Positive controls:

    • Cells or tissues treated with tyrosine phosphatase inhibitors

    • Systems known to express phosphorylated CAV2

  • Negative controls:

    • Phosphatase-treated samples to remove phosphorylation

    • CAV2 knockdown or knockout samples

    • Peptide competition assays to demonstrate specificity

  • Comparative analysis:

    • Use antibodies against total CAV2 in parallel experiments

    • Calculate phospho-CAV2/total CAV2 ratios for more accurate assessment of phosphorylation status

How can I maximize signal detection when phosphorylated CAV2 is present at low levels?

For detecting low-abundance phosphorylated proteins:

  • Sample enrichment:

    • Consider immunoprecipitation with total CAV2 antibody followed by Western blotting with the phospho-specific antibody

    • Use phosphotyrosine enrichment techniques prior to analysis

  • Signal amplification:

    • Employ highly sensitive chemiluminescent substrates

    • Consider using signal enhancers specifically designed for phosphoprotein detection

    • Longer exposure times may be necessary, but be cautious of increased background

  • Increase phosphorylation status:

    • Treat samples with phosphatase inhibitors

    • Use stimuli known to enhance tyrosine phosphorylation (EGF, pervanadate treatment)

How might CAV2 Tyr27 phosphorylation relate to calcium channel regulation and neuronal function?

The relationship between CAV2 phosphorylation and calcium channel function represents an emerging area of research:

  • Potential mechanistic connections:

    • Caveolins may regulate calcium channel trafficking to the membrane

    • Phosphorylated CAV2 might directly interact with calcium channel subunits

    • May influence calcium channel clustering in specific membrane domains

  • Experimental approaches:

    • Co-immunoprecipitation studies to detect interactions between phosphorylated CAV2 and calcium channel subunits

    • Electrophysiological studies measuring calcium currents in systems with modified CAV2 phosphorylation

Research has shown that calcium channels like Cav2.1 and Cav2.2 are regulated by phosphorylation events and protein interactions . For example, ankyrin-B associates with Cav2.1/Cav2.2 through a conserved motif in the DII/III loop domain, and mutation of a conserved tyrosine residue in this motif disrupts this association . This suggests tyrosine phosphorylation plays critical roles in channel regulation, potentially involving caveolin-mediated pathways.

What techniques can be employed to study the temporal dynamics of CAV2 Tyr27 phosphorylation?

To investigate the temporal aspects of phosphorylation:

  • Time-course experiments:

    • Stimulate cells with appropriate agonists and collect samples at defined intervals

    • Western blot with phospho-specific antibody to track phosphorylation levels over time

  • Live-cell imaging approaches:

    • FRET-based biosensors designed to detect CAV2 phosphorylation state

    • Phospho-specific antibody fragments coupled to fluorescent proteins for live detection

  • Super-resolution microscopy:

    • Track phosphorylated CAV2 localization with high spatial resolution

    • Correlate with functional measurements of cellular processes

How might CAV2 Tyr27 phosphorylation status be relevant to disease models?

Potential implications in disease:

  • Cancer research:

    • Altered tyrosine phosphorylation is common in many cancers

    • Caveolin function has been implicated in tumor progression and metastasis

  • Cardiovascular disease:

    • Caveolins play important roles in vascular function

    • Phosphorylation may influence endothelial cell responses to stress or injury

  • Neurological disorders:

    • Given the potential role in calcium channel regulation, altered CAV2 phosphorylation might impact neuronal excitability and function

    • Could be relevant in disorders involving calcium signaling dysregulation

The methodologies for studying these disease connections would include comparing phosphorylation levels between normal and diseased tissues, creating phosphomimetic or phospho-deficient CAV2 mutants, and examining their effects in cellular or animal models of disease.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.